Metabolic syndrome and kidney disease

Blood Purification

Volumn 26, Issue 1, 2008, Pages 59-62

  Ritz, Eberhard ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Nierenzentrum   (Germany)

Author keywords

Aldosterone; Hyperfiltration; Insulin resistance; Metabolic syndrome; Microalbuminuria; Obesity

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CONFERENCE PAPER; DISEASE ASSOCIATION; FOCAL GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; INSULIN RESISTANCE; KIDNEY BLOOD FLOW; KIDNEY DISEASE; KIDNEY FUNCTION; METABOLIC SYNDROME X; OBESITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTEINURIA; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

ALBUMINURIA; BODY FAT DISTRIBUTION; BODY MASS INDEX; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; METABOLIC SYNDROME X; OBESITY; RENIN-ANGIOTENSIN SYSTEM;

EID: 38049078776     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000110566     Document Type: Conference Paper

References (30)

1. Hitzenberger K, Richter-Quittner M: Ein Beitrag zum Stoffwechsel bei der vaskulären Hypertonie. Wien Arch Inn Med 1921;2:189.
2. Reaven GM: Banting Lecture 1988: role of insulin resistance in human disease. Diabetes 1988;37:1595-1607.
3. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Adult Treatment Panel III. JAMA 2001;285:2486-2497.
4. Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, Haffner SM, Isles C, Macfarlane PW, Packard CJ, Cobbe SM, Shepherd J: Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003;108:414-419.
5. Kahn R, Buse J, Ferrannini E, Stern M: The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005;28:2289-2304.
6. Reaven GM: The metabolic syndrome: requiescat in pace. Clin Chem 2005;51:931-938.
7. Pambianco G, Costacou T, Orchard TJ: The prediction of major outcomes of type 1 diabetes: a 12-year prospective evaluation of three separate definitions of the metabolic syndrome, and their components and estimated glucose disposal rate: the Pittsburgh Epidemiology of Diabetes Complications Study Experience. Diabetes Care 2007;30:1248-1254.
8. Ejerblad E, Fored CM, Lindblad P, Fryzek J, McLaughlin JK, Nyren O: Obesity and risk for chronic renal failure. J Am Soc Nephrol 2006;17:1695-1702.
9. Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D: Predictors of new-onset kidney disease in a community-based population. JAMA 2004;291:844-850.
10. Iseki K, Ikemiya Y, Kinjo K, Inoue T, Iseki C, Takishita S: Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 2004;65:1870-1876.
11. Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS: Body mass index and risk for end-stage renal disease. Ann Intern Med 2006;144:21-28.
12. Stengel B, Tarver-Carr ME, Powe NR, Eberhardt MS, Brancati FL: Lifestyle factors, obesity and the risk of chronic kidney disease. Epidemiology 2003;14:479-487.
13. Chagnac A, Weinstein T, Korzets A, Ramadan E, Hirsch J, Gafter U: Glomerular hemodynamics in severe obesity. Am J Physiol Renal Physiol 2000;278:F817-F822.
14. Cohen AH: Massive obesity and the kidney. A morphologic and statistical study. Am J Pathol 1975;81:117-130.
15. Weisinger JR, Kempson RL, Eldridge FL, Swenson RS: The nephrotic syndrome: a complication of massive obesity. Ann Intern Med 1974;81:440-447.
16. Praga M, Hernandez E, Morales E, Campos AP, Valero MA, Martinez MA, Leon M: Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis. Nephrol Dial Transplant 2001;16:1790-1798.
17. Bonnet F, Deprele C, Sassolas A, Moulin P, Alamartine E, Berthezene F, Berthoux F: Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis. Am J Kidney Dis 2001;37:720-727.
18. Morales E, Valero MA, Leon M, Hernandez E, Praga M: Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. Am J Kidney Dis 2003;41:319-327.
19. Pinto-Sietsma SJ, Navis G, Janssen WM, de Zeeuw D, Gans RO, de Jong PE: A central body fat distribution is related to renal function impairment, even in lean subjects. Am J Kidney Dis 2003;41:733-741.
20. Chen J, Gu D, Chen CS, Wu X, Hamm LL, Muntner P, Batuman V, Lee CH, Whelton PK, He J: Association between the metabolic syndrome and chronic kidney disease in Chinese adults. Nephrol Dial Transplant 2007;22:1100-1106.
21. Kurella M, Lo JC, Chertow GM: Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol 2005;16:2134-2140.
22. Barker DJ: The origins of the developmental origins theory. J Intern Med 2007;261:412-417.
23. Lurbe E, Garcia-Vicent C, Torro I, Fayos JL, Aguilar F, de Llano JM, Fuertes G, Redón J: First-year blood pressure increase steepest in low birthweight newborns. J Hypertens 2007;25:81-86.
24. Keijzer-Veen MG, Schrevel M, Finken MJ, Dekker FW, Nauta J, Hille ET, Frolich M, van der Heijden BJ: Microalbuminuria and lower glomerular filtration rate at young adult age in subjects born very premature and after intrauterine growth retardation. J Am Soc Nephrol 2005;16:2762-2768.
25. Hall JE, Kuo JJ, da Silva AA, de Paula RB, Liu J, Tallam L: Obesity-associated hypertension and kidney disease. Curr Opin Nephrol Hypertens 2003;12:195-200.
26. Suzuki M, Kimura Y, Tsushima M, Harano Y: Association of insulin resistance with salt sensitivity and nocturnal fall of blood pressure. Hypertension 2000;35:864-868.
27. Rocchini AP, Katch V, Kveselis D, Moorehead C, Martin M, Lampman R, Gregory M: Insulin and renal sodium retention in obese adolescents. Hypertension 1989;14:367-374.
28. Pearce D: The role of SGK1 in hormone-regulated sodium transport. Trends Endocrinol Metab 2001;12:341-347.
29. Nagase M, Yoshida S, Shibata S, Nagase T, Gotoda T, Ando K, Fujita T: Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: possible contribution of fat-derived factors. J Am Soc Nephrol 2006;17:3438-3446.
30. Goodfriend TL, Ball DL, Egan BM, Campbell WB, Nithipatikom K: Epoxy-keto derivative of linoleic acid stimulates aldosterone secretion. Hypertension 2004;43:358-374.